Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

ELIXINOL GLOBAL LIMITED

INVESTOR PRESENTATION - ELIXINOL GLOBAL LIMITED

ASX:EXL

ELIXINOL GLOBAL LIMITED

Consumer Staples

Elixinol Global Limited (EXL) manufactures and distributes pharmaceutical products. The Company offers industrial hemp and medicinal cannabis based dietary supplements and skin care products. Elixinol Global serves customers worldwide. The Elixinol Group operates (or intends to operate) in the industrial hemp and medicinal cannabis industries via Elixinol US, Elixinol AUS and HFA.

Read more

Market Cap

$45.80m

Price at Close

$0.19

4w avg. Volume

2.63m

4w avg. Turnover

$508.23k

Announcements
announcementt+2 movementdate
  • Becoming a substantial holder

    Shareholder Details

  • -

    24 Nov 2020

-

24 Nov 2020
  • Change in Substantial Holding - Paul Benhaim

    Shareholder Details

  • +15.15%

    23 Nov 2020

+15.15%

23 Nov 2020
  • Share Purchase Plan

    Issued Capital

  • -2.94%

    19 Nov 2020

-2.94%

19 Nov 2020
  • Appendix 2A

    Issued Capital

  • -2.94%

    19 Nov 2020

-2.94%

19 Nov 2020
  • Cleansing Statement

    Issued Capital

  • -2.94%

    19 Nov 2020

-2.94%

19 Nov 2020
  • Update - Proposed issue of Securities - EXL

    Issued Capital

  • -2.94%

    19 Nov 2020

-2.94%

19 Nov 2020
  • Response to ASX Query Letter

    ASX Query · Market sensitive

  • -2.94%

    19 Nov 2020

-2.94%

19 Nov 2020
  • Proposed issue of Securities - EXL

    Issued Capital

  • -5.41%

    15 Nov 2020

-5.41%

15 Nov 2020
  • Completion of Institutional Offer

    Issued Capital · Market sensitive

  • -5.41%

    15 Nov 2020

-5.41%

15 Nov 2020
  • Trading Halt

    Stock Exchange Announcement · Market sensitive

  • 0.00%

    12 Nov 2020

0.00%

12 Nov 2020
Market Data

Current Price

$0.19

52WK HIGH

$1.43

52WK LOW

$0.14

1YR RETURN

-82.73%

1YR RETURN VS. SECTOR

-82.49%

90 DAY RETURN

+18.75%

ASX RANK

1,137

/2,024

SECTOR RANK

6

/8

SHARES OUTSTANDING

241.05m
ASX:EXL

ELIXINOL GLOBAL LIMITED

Consumer Staples

Elixinol Global Limited (EXL) manufactures and distributes pharmaceutical products. The Company offers industrial hemp and medicinal cannabis based dietary supplements and skin care products. Elixinol Global serves customers worldwide. The Elixinol Group operates (or intends to operate) in the industrial hemp and medicinal cannabis industries via Elixinol US, Elixinol AUS and HFA.

Read more

Market Cap

$45.80m

Price at Close

$0.19

4w avg. Volume

2.63m

4w avg. Turnover

$508.23k

ASX:EXL is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.